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PATHOGENESIS OF KIDNEY AND LIVER
LESIONS UNDER CONDITIONS OF 2,4-
DINITROFENOL ADMINISTRATION
Abstract. From the positions of probative medicine the work presents
theoretical substantiation and a new approach to solve the scientific
task concerning early pathogenesis mechanisms of pseudohepatorenal
syndrome as the basis to deteriorate the course of kidney and liver
failure with breaking oxidative phosphorylation under conditions of
2,4-dinitrofenol administration. The experiments were conducted on
120 albino outbred male rats with the body weight of 0,16-0,20 kg fed
on low-sodium diet with tissue hypoxia modeling.
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2,4-dinitrofenol administration is known to cause
the development of acute tissue hypoxia [4] due to
the break of oxidative phosphorylation resulting in
renal disorders with disturbance of the main energy-
dependent process – reabsorption of sodium ions and
proteins in the proximal portions of the nephron, and
liver lesions [1]. Cytokines, the products of protein
oxidative modification, may promote the develop-
ment of early mechanisms of liver and kidney lesions
with the formation of syndromes of translocation and
sodium ions loss with urine. The antioxidant mela-
tonin is reasonable to be used as means of pathogenic
correction.
Objectives
To specify early mechanisms of liver and kidney
lesions under conditions of low sodium diet with
acute tissue hypoxia caused by 2,4-dinitrofenol
administration with elaboration of ways to correct
pathogenesis of the lesions detected by means of
melatonin use.
Materials and methods
Acute tissue hypoxia was modeled by means of
single intraperitoneal injection of 0.1% 2,4-
dinitrofenol solution in the dose of 3 mg/kg in the
experiment conducted on 120 male albino outbred
rats with the body weight of 0,16-0,20 kg [3].
Rats’ resistance to acute hypoxia was estimated
by the time of their position loss on the “high-altitude
plateau” of acute hypobaric hypoxia and the time of
general animal stay from the moment of reaching the
“height” of 12000 m to the appearance of the second
agonic inspiration (life time or reserve time), as well
as by the time of restoration of the position from the
beginning of the descending moment. There were
three groups of animals divided: highly, average, and
low resistant [2]. All the following study was
conducted on the average resistant rats.
The portions of the liver and kidney tissues during
48 hours were fixed in 10% neutral buffered formalin
solution, followed by dehydration procedure in the
ascending ethanol battery and paraffin coating at the
temperature 580C. To estimate protein oxidative
modification histological sections were stained with
bromphenol blue. Computed spectrometry was made
by means of ColorPic computer program (Graphic Art
Tools, 2004). Histochemical technique to determine
the ration between the principal and acid groups of
proteins was based on the measurement of intensity of
red and blue spectrum colours during computer-
spectral analysis of microscopic objects digital images
and calculation of R/B coefficient, as the ratio between
the staining intensity in the portion of red spectrum (R)
and in the portion of blue one (B) [7, 10].
Functional state of the kidneys was examined by
water diuresis simulated by tap water injected
intragastrically through a metal probe and heated to
370C in the volume of 5% out of body weight. The
volume of diuresis (V) was estimated in ml/2 hours Ì
100 g. After water load with the aim to obtain plasma
the animals were decapitated under mild ether
narcosis, the blood was taken into tubes with heparin.
Glomerular filtration rate was estimated by endogenic
creatinine clearance calculated by the formula:
Ñcr = Ucr 
 Ì V/Pcr,
where Ucr and Pcr stand for creatinine concen-
tration in the urine and blood plasma respectively.
The concentration of sodium and potassium ions in
the urine and blood plasma was estimated by
photometry, protein concentration in the urine was
detected by sulfosalicylic method. Proximal and
distal reabsorption of sodium ions was examined
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(TpNa+, TdNa+). The calculations were made by the
formulae:
       TpNa+  = (Ccr - V) Ì  PNa+
       TdNa+  = (PNa+-  UNa+) Ì V [8]
Blood cytokines were detected by immuno-
enzymatic method [9]. Exogenic melatonin was
injected in the single dose of 3,5 mg/kg [10].
Statistical calculation of the data obtained was
made by the computer program “Statgrafics” and “Excell
7.0”. All the experiments were conducted according to the
European Council Convention on vertebrate animal
protection used in experiments and other scientific research
(dated 18.03.1986), the European Union Direction No 609
(dated 24.11.1986), the Orders of the Ministry of Public
Health of Ukraine No 960 (dated 23.09.2009) and No 944
(dated 14.12.2009).
Results and Discussion
The results of the experiment demonstrated
increased concentration of tumour necrosis factor-α,
interleukin-1β, interleukin-6 in the blood plasma
(fig.1) 2 hours after 2,4-dinitrofenol injection in the
dose of 3 mg/kg under conditions of low sodium diet.
Under conditions of 2,4-dinitrofenol injection
urination reduced, the concentration of potassium
ions, proteins in the urine increased, GFR was
inhibited (table 1). Creatinine concentration in the
blood plasma and urine did not change. The transport
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of sodium ions under conditions of 2,4-dinitrofenol
injection was characterized by increased concen-
tration of sodium ions in the urine. Proximal reab-
sorption of sodium ions was characterized by the
tendency to inhibition, and distal reabsorption of this
electrolyte was reliably decreased. The concentration
of sodium ions in the blood plasma was not changed.
Fig.2 presents forest-diagram of the comparative
characteristics of melatonin protective effect upon
the epithelial cytoplasm R/B coefficient of the
proximal tubules, sodium ions excretion, sodium
ions clearance, concentration index of sodium ions 2
hours after 2,4-dinitrofenol injection in the dose of 3
mg/kg under conditions of low sodium diet with
water-induced diuresis in the volume of 5% out of body
weight. The control for all the experiments is presented
by a horizontal line and assumed as 1. As it is seen from
the diagram the most protective effect under conditions
of the experiment was produced by melatonin upon the
concentration index of sodium ions.
2,4-dinitrofenol injection resulted in the inten-
sification of oxidative protein modification by the
increase of R/B index in the proximal tubules,
medullar thick ascending portions of the nephron
loop, accumulating tubules of the renal papillae, and
in the protein mass of hepatocyte cytoplasm (table 2).
2,4-dinitrofenol injection caused an average twice
reduction of ATP level in the renal tubules [2] at the
expense of  breaking oxidative phosphorylation. ATP
deficiency caused disorders of the main energy-
dependent process of the renal tubules – sodium ions
reabsorption, leading to the development of the
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examined cation loss. The above mentioned facts are
evidenced by the increased concentration of sodium
ions in the urine. The tendency to reduce proximal
reabsorption of sodium ions is stipulated by
“obscured” lesions of the proximal nephron portion
[5], and a reliable decrease of the examined cation
distal reabsorption  is caused by the fact, that
transport processes in the distal tubule are more
energy-dependent than in the proximal nephron
portion. At the same time, the degree of loss
syndrome was not considerable, as the concentration
of sodium ions in the blood plasma was not changed,
and not considerable activation of rennin-
angiotensin-aldosterone system caused only reliable
decrease of diuresis, increased concentration of
potassium ions in the urine with the tendency to
inhibit glomerular filtration.
Barrier lesions of the intestine and liver against a
background of energy-deficiency resulted in the
translocation of endotoxin from the intestinal lumen
into the blood [6], which in its turn, caused increased
concentration of tumour necrosis factor-α, interleukin-
1-β, interleukin-6 [2, 3, 4], which in their turn,
provoked additional reactions of renal tubules lesions
with intensification of sodium ions loss syndrome.
On the basis of the data obtained a generalized
scheme of pseudohepatorenal syndrome patho-
genesis under conditions of 2,4-dinitrofenol injection
can be suggested [11, 12] , reflecting a theoretical
substantiation and new solution of a scientific task
concerning early mechanisms of pseudohepatorenal
syndrome pathogenesis as the basis to deteriorate the
course of renal and liver failure with breaking
oxidative phosphorylation under conditions of 2,4-
dinitrofenol injection (fig.3).
Under conditions of low sodium diet 2 hours after
modeling tissue hypoxia and 2,4-dinitrofenol injec-
tion increased concentration of TNF-α, IL-1β and
IL-6 in the blood plasma was found, increased degree
of oxidative modified proteins in the liver and
kidneys of rats by R/B coefficient was detected,
causing lesions of the liver and kidneys, disorders of
energy metabolism with the development of the
syndrome of translocation and sodium ions loss with
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urine and its secretion increase. Melatonin due to its
antioxidant properties demonstrated its protective
effect upon the course of pseudohepatorenal syn-
drome under conditions of tissue hypoxia, revealing
its protective influence upon the degree of oxidative
modified proteins in the liver and kidneys of rats,
reduced the level of R/B coefficient in the proximal,
and distal portions of the nephron, accumulating
tubules of the renal papillae and protein mass of
hepatocyte cytoplasm as compared with the readings
under 2,4-dinitrofenol intoxication.
Conclusion
From the positions of probative medicine the
experimental work, conducted on outbred mature
male rats, presents theoretical substantiation and a
new approach to solve the scientific task concerning
early pathogenesis mechanisms of pseudohepato-
renal syndrome as the basis to deteriorate the course
of kidney and liver failure with breaking oxidative
phosphorylation under conditions of 2,4-dinitrofenol
administration.
Prospects of further research
To specify the role of antiinflammatory cytokines
in pathogenesis of pseudohepatorenal syndrome
under conditions of 2,4-dinitrofenol injection.
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âî¿ ìåäèöèíè íàâåäåíî òåîðåòè÷íå óçàãàëüíåííÿ òà íîâå âè-
ð³øåííÿ íàóêîâî¿ çàäà÷³ ùîäî ðàíí³õ ìåõàí³çì³â ïàòîãåíåçó
ïñåâäîãåïàòîðåíàëüíîãî ñèíäðîìó ÿê îñíîâè ïîã³ðøåííÿ
ïåðåá³ãó íèðêîâî¿ òà ïå÷³íêîâî¿ íåäîñòàòíîñò³ ïðè ðîç’ºä-
íàíí³ îêèñíåííÿ ³ ôîñôîðèëþâàííÿ çà óìîâ óâåäåííÿ 2,4-
äèí³òðîôåíîëó.
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îòíîñèòåëüíî ðàííèõ ìåõàíèçìîâ ïàòîãåíåçà ïñåâäî-
ãåïàòîðåíàëüíîãî ñèíäðîìà êàê îñíîâû óõóäøåíèÿ òå÷åíèÿ
ïî÷å÷íîé è ïå÷åíî÷íîé íåäîñòàòî÷íîñòè ïðè ðàñùåïëåíèå
îêèñëåíèÿ è ôîñôîðèëèðîâàíèÿ ïðè ââåäåíèè 2,4-
äèíèòðîôåíîëà.
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